Business Wire

TMRW

7.12.2021 15:50:06 CET | Business Wire | Press release

Share
Sunny Varkey Launches Tmrw, a New Learning Operating System (LearnOS) for Global Education to Bring a Quality Education Within Reach of Every Child

Tmrw, a new and scalable Learning Operating System (LearnOS) for global education with a mission to help bring a quality education to every child, was launched this month.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207005768/en/

Its interoperable All-In-One Integrated Platform is built to be accessible and affordable for Government funded schools operating in both the developed and developing world settings. In particular, it seeks to reach all students irrespective of their background or their ability to pay. It is designed to cater to the needs of every curriculum, context and mode of learning, whether brick and mortar, virtual or blended. Tmrw’s vision over time is to underpin learning, teaching, and the operational needs of K12 education, higher education and life-long learning.

Sunny Varkey, who also founded the Global Teacher Prize, has ensured that Tmrw has been teacher-led from the drawing board to its final roll-out. Uniquely, he has been able to draw upon the teaching talent within the GEMS schools network, which includes 20,000 inspired and qualified teachers, teaching support staff and school administrators from all nationalities, delivering seven different curricula in 16 countries.

The ongoing COVID-19 pandemic has emphasised the urgent need for an integrated technological solution for global education that can streamline end-to-end processes and utilise data to improve teaching and learning, while providing a seamless experience for all. Tmrw seeks to fill this void by providing an education eco-system that offers far more than a traditional, stand-alone learning or school management system. Working in collaboration with schools and teachers, our ambition is that Tmrw becomes an accepted LearnOS of global education – giving every learner an opportunity to participate in the future.

Tmrw’s EdTech platform includes a comprehensive suite of modules that can be introduced as a full ecosystem or as bolt-ons that are interoperable with technologies from other providers, offering schools the efficiency gains that integration can bring.

The platform includes modules to manage and oversee the curriculum, assessment, and track student progress. It has non-academic functionalities such as sports management, counselling and well-being. It allows schools to manage parent and student relations and includes custom-built health and child safety guarding features. It also includes back-office operations such as revenue management, HR, payroll, finance and procurement.

Tmrw is not just a technology company, but an education transformation company that offers comprehensive educational services such as:

  • Tmrw Academy – focused on professional development including teacher training
  • Education Command Center – serving policy makers with real-time decision-making capabilities at a national level
  • Tech-In-A-Box – Comprehensive technology backbone covering the school eco system end to end.
  • Tmrw Advisory Services for educational institutions on curriculum design, digital transformation, school improvement and nation-wide educational strategies.

Spun out from GEMS Education, Tmrw has been incorporated as the independent technology entity of GEMS and so will draw on the experience of the largest private K-12 education provider in the world, where its solutions have proven themselves to be scalable and effective with real students in a real classroom environment. GEMS Education, since it was founded 62 years ago, has provided a quality and values driven education throughout the world.

During the pandemic, GEMS Education moved seamlessly online from the start of the crisis because for the last decade it has built, tested, and constantly improved an education platform with real teachers and real students in real classrooms. This culture of improvement, driven both by analytics and constant engagement with the experience of teachers and partners, will be at the heart of Tmrw.

Today, GEMS is the only private-sector education operator with an all-inclusive platform for teachers, pupils, and parents. That experience is the foundation of Tmrw, which seeks to create an impact on a billion learners through technology, backed by a team that has touched millions of lives over decades.

Mr. Sunny Varkey, Chairman and Founder of Tmrw and GEMS Education, said:

“Quality education is the great equaliser. It bridges the gap between the rich and the poor and gives us the greatest opportunity to improve the state of our world.

“We have built this platform to be accessible and affordable for Government funded schools throughout the world to help improve learning outcomes wherever we can. We seek to reach all students irrespective of their background or their ability to pay. Ultimately, our vision is to give every child their birth-right of a great education and provide hope for a better future.

“We can only achieve this mission if we learn lessons from the frontline of education. For far too long edtech has side-lined the voice of the teacher. Not this time, as teachers will be the beating heart of Tmrw. They will be our designers, our content creators and our toughest critics.”

Tmrw CEO and GEMS Education Group Chief Disruption Officer, Mr Krishnan Gopi, said:

“Education is transforming at pace, moving away from the conventional patterns of teaching and learning that have dominated the sector. There is an undeniable, growing awareness among educators and families that education must evolve to meet tomorrow’s reality.

“Designed by educators for educators, Tmrw will help students learn better, teachers teach better, parents become more engaged, and schools become more efficient”.

Our platform is secure, scalable, multi-lingual and highly configurable to meet different needs of education systems across the globe. It utilizes exponential technologies such as AI / ML, AR /VR, Blockchain and IOT to revolutionise the teaching and learning experience.

*For more information about how Tmrw can empower schools to deliver enhanced teaching and learning outcomes please email: info@tmrw.group

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye